Ιωάννης Ταρνανάς | Cretalive
TGL2019 - Dr. Ioannis Tarnanas - YouTube
Ioannis Tarnanas's Page – iACToR
Ioannis Tarnanas presentations | SlideShare
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Ioannis Tarnanas (@ITarnanas) / Twitter
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
PDF) Ecological Validity of Virtual Reality Daily Living Activities Screening for Early Dementia: Longitudinal Study
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
PDF) Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study
Ioannis Tarnanas - Worldwebforum
Loop | Ioannis Tarnanas
Handbook of Research on Innovations in the Diagnosis and Treatment of Dementia: 9781466682344: Medicine & Health Science Books @ Amazon.com
Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for
Greek Researcher Receives Top European Innovation Award
Greek Researcher Receives Top European Innovation Award (video)
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Dr. Ioannis Tarnanas, Ph.D. | LinkedIn
Ioannis Tarnanas | Nature Portfolio Health Community
Stream Ioannis Tarnanas: Atlantic Equity for Equity in Brain Health by Atlantic Fellows | Listen online for free on SoundCloud
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
